Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Philipps University Marburg
With
German Research Foundation
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Primary diagnosis of invasive epithelial ovarian cancer FIGO stage IIB-IV (IV only if resectable metastasis in pleura, liver, spleen, and/or abdominal wall)
Macroscopic complete resection
Age: 18 - 75 years
Patients who have given their signed and written informed consent
Good performance status (ECOG 0/1)
You may not be if
Non epithelial ovarian malignancies and borderline tumors
Secondary invasive neoplasms in the last 5 years (except synchronal endometrial carcinoma FIGO IA G1/2, non melanoma skin cancer, breast cancer T1 N0 M0 G1/2) or with any signs of relapse or activity.
Recurrent ovarian cancer
Prior chemotherapy for ovarian cancer or abdominal/pelvic radiotherapy
Diseases of the lymph system (including lymph edema of unknown origin)
Clinical relevant dysfunctions of blood clotting (including medicamentous conditioned reasons, e.g. ASS, if not stopped at least 7 days prior to surgery)
Any significant medical reasons, age or performance status that will not allow to perform the study procedures (estimation of investigator)
Prior retroperitoneal lymph node dissection (systematic or sampling)
Pregnancy
Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent
Any reasons interfering with regular follow-up
Clareo Health | Lymphadenectomy In Ovarian Neoplasms
